Zura Bio Limited
ZURA
$4.75
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.72% | 14.18% | 79.42% | 68.93% | 65.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.34% | 44.31% | 75.85% | 4.37% | -11.89% |
| Operating Income | -36.34% | -44.31% | -75.85% | -4.37% | 11.89% |
| Income Before Tax | -31.00% | -37.77% | -94.61% | -6.12% | 13.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.00% | -37.77% | -94.61% | -6.12% | 13.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.00% | -37.77% | -94.61% | -6.12% | 13.18% |
| EBIT | -36.34% | -44.31% | -75.85% | -4.37% | 11.89% |
| EBITDA | -60.67% | -133.40% | -515.21% | -- | -- |
| EPS Basic | -92.57% | -15.14% | -45.51% | 56.02% | 87.51% |
| Normalized Basic EPS | -5.73% | 3.09% | -12.81% | 52.95% | 79.62% |
| EPS Diluted | -92.57% | -15.14% | -45.51% | 56.02% | 87.51% |
| Normalized Diluted EPS | -5.73% | 3.09% | -12.81% | 52.95% | 79.62% |
| Average Basic Shares Outstanding | 25.48% | 45.47% | 69.40% | 97.66% | 127.76% |
| Average Diluted Shares Outstanding | 25.48% | 45.47% | 69.40% | 97.66% | 127.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |